Overwhelming Support for HIG Capital's Acquisition of Converge Technology
April 10, 2025 - 17:20
In a significant development for Converge Technology, shareholders have overwhelmingly approved the acquisition by HIG Capital, with an impressive 98.85% voting in favor of the deal. The acquisition involves a cash offer of C$6.00 per share, marking a pivotal moment for the company as it seeks to enhance its growth and operational capabilities.
The transaction is expected to be completed by April 22, signaling a new chapter for Converge Technology. This acquisition is anticipated to provide the company with increased resources and strategic support, aligning with its long-term goals in the technology sector.
The strong shareholder backing underscores confidence in HIG Capital's ability to drive Converge Technology forward and capitalize on emerging opportunities in the market. As the completion date approaches, stakeholders are eager to see how this partnership will unfold and what it means for the future of Converge Technology in an increasingly competitive landscape.
MORE NEWS
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...